That number is not just large in absolute terms, it is the largest weight-loss signal ever reported in a randomized Phase 3 trial of a GLP-1-class compound, and it arrived with additional secondary findings that reframe what "GLP-1 therapy" could eventually mean: a 75.8% reduction in osteoarthritis pain, a roughly 20% drop in LDL cholesterol, and a 72% reversal rate of prediabetes to normoglycemia in the affected subpopulation
Physiological Reviews, 87(4), 1409-1439
Eur J Med Chem
The Science Behind GLP-3 (Reta) 10mg Product Name: GLP-3 (Retatrutide) Strength: 10mg Chemical Name: Triple GLP-1 / GIP / Glucagon Receptor Agonist CAS Number: 2381089-83-2 Molecular Formula: CHFNO Molecular Weight: 4845.44 g/mol Amino Acid Sequence: GLP-1 / GIP / Glucagon Analogue Appearance: White to Off-White Lyophilized Powder Classification: Advanced Peptide Hormone Analogue Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) How GLP-3 (Reta) 10mg Is Studied in Metabolic Research Metabolic & Weight Research You May Also Like Researched for metabolic research $69.99
Consider your comfort with rapid assessment versus comprehensive intake, your need for behavioral coaching, your medication sourcing preference (branded versus compounded), and cost
Zheng S, Huang H, Chen H, Liu Y